REQUEST A DEMO
Total
USD $0.00
Search more companies

Cureclip Pharmaceuticals Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cureclip Pharmaceuticals Limited Profile Updated: April 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Cureclip Pharmaceuticals Limited is based in India, with the head office in North West Delhi. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on November 22, 1990. Over the same period, its total assets decreased by 30.97%. The net profit margin of Cureclip Pharmaceuticals Limited increased by 0.88% in 2025.

Headquarters
Unit No. 1273 12Th Floor Aggarwal Cyber Plaza 2 Netaji Subash Place Pitampura Delhi In-Dl In 110034
North West Delhi; Delhi; Postal Code: 110034

Contact Details: Purchase the Cureclip Pharmaceuticals Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Cureclip Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Cureclip Pharmaceuticals Limited report to view the information.
Incorporation Date:
November 22, 1990
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
66.05%
Purchase this report to view the information.
10.87%
Company Performance
Financial values in the chart are available after Cureclip Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Total Operating Revenue
-93.73%
Operating Profit
N/A
EBITDA
-87.4%
Net Profit/Loss for the Period
-1511.83%
Total Assets
-30.97%
Total Equity
-57.37%
Net Profit Margin
0.88%
Return on Equity (ROE)
-131.01%
Debt / Equity
284.35%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?